About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Botanical Drugs Market Size, Share & Growth by 2033
Botanical Drugs Market
Select Regional / Country Report
Global Canada India United States

Botanical Drugs Market Size, Share & Trends Analysis Report By Source (Plant-Based, Algae-Based, Fungi-Based), By Form (Tablets, Capsules, Powders, Solutions, Others), By Therapeutic Indication (Cardiovascular Diseases, Respiratory Diseases, Gastrointestinal Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Providers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH1747DR
Last Updated : November 12, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Botanical Drugs Market Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Plant-Based
        1. By Value
      3. Algae-Based
        1. By Value
      4. Fungi-Based
        1. By Value
    3. By Form
      1. Introduction
        1. Form By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powders
        1. By Value
      5. Solutions
        1. By Value
      6. Others
        1. By Value
    4. By Therapeutic Indication
      1. Introduction
        1. Therapeutic Indication By Value
      2. Cardiovascular Diseases
        1. By Value
      3. Respiratory Diseases
        1. By Value
      4. Gastrointestinal Disorders
        1. By Value
      5. Others
        1. By Value
    5. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Providers
        1. By Value
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Plant-Based
        1. By Value
      3. Algae-Based
        1. By Value
      4. Fungi-Based
        1. By Value
    3. By Form
      1. Introduction
        1. Form By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powders
        1. By Value
      5. Solutions
        1. By Value
      6. Others
        1. By Value
    4. By Therapeutic Indication
      1. Introduction
        1. Therapeutic Indication By Value
      2. Cardiovascular Diseases
        1. By Value
      3. Respiratory Diseases
        1. By Value
      4. Gastrointestinal Disorders
        1. By Value
      5. Others
        1. By Value
    5. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Providers
        1. By Value
    6. U.S.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Plant-Based
          1. By Value
        3. Algae-Based
          1. By Value
        4. Fungi-Based
          1. By Value
      2. By Form
        1. Introduction
          1. Form By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powders
          1. By Value
        5. Solutions
          1. By Value
        6. Others
          1. By Value
      3. By Therapeutic Indication
        1. Introduction
          1. Therapeutic Indication By Value
        2. Cardiovascular Diseases
          1. By Value
        3. Respiratory Diseases
          1. By Value
        4. Gastrointestinal Disorders
          1. By Value
        5. Others
          1. By Value
      4. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Providers
          1. By Value
    7. Canada
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Plant-Based
        1. By Value
      3. Algae-Based
        1. By Value
      4. Fungi-Based
        1. By Value
    3. By Form
      1. Introduction
        1. Form By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powders
        1. By Value
      5. Solutions
        1. By Value
      6. Others
        1. By Value
    4. By Therapeutic Indication
      1. Introduction
        1. Therapeutic Indication By Value
      2. Cardiovascular Diseases
        1. By Value
      3. Respiratory Diseases
        1. By Value
      4. Gastrointestinal Disorders
        1. By Value
      5. Others
        1. By Value
    5. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Providers
        1. By Value
    6. U.K.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Plant-Based
          1. By Value
        3. Algae-Based
          1. By Value
        4. Fungi-Based
          1. By Value
      2. By Form
        1. Introduction
          1. Form By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powders
          1. By Value
        5. Solutions
          1. By Value
        6. Others
          1. By Value
      3. By Therapeutic Indication
        1. Introduction
          1. Therapeutic Indication By Value
        2. Cardiovascular Diseases
          1. By Value
        3. Respiratory Diseases
          1. By Value
        4. Gastrointestinal Disorders
          1. By Value
        5. Others
          1. By Value
      4. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Providers
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Plant-Based
        1. By Value
      3. Algae-Based
        1. By Value
      4. Fungi-Based
        1. By Value
    3. By Form
      1. Introduction
        1. Form By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powders
        1. By Value
      5. Solutions
        1. By Value
      6. Others
        1. By Value
    4. By Therapeutic Indication
      1. Introduction
        1. Therapeutic Indication By Value
      2. Cardiovascular Diseases
        1. By Value
      3. Respiratory Diseases
        1. By Value
      4. Gastrointestinal Disorders
        1. By Value
      5. Others
        1. By Value
    5. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Providers
        1. By Value
    6. China
      1. By Source
        1. Introduction
          1. Source By Value
        2. Plant-Based
          1. By Value
        3. Algae-Based
          1. By Value
        4. Fungi-Based
          1. By Value
      2. By Form
        1. Introduction
          1. Form By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powders
          1. By Value
        5. Solutions
          1. By Value
        6. Others
          1. By Value
      3. By Therapeutic Indication
        1. Introduction
          1. Therapeutic Indication By Value
        2. Cardiovascular Diseases
          1. By Value
        3. Respiratory Diseases
          1. By Value
        4. Gastrointestinal Disorders
          1. By Value
        5. Others
          1. By Value
      4. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Providers
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Plant-Based
        1. By Value
      3. Algae-Based
        1. By Value
      4. Fungi-Based
        1. By Value
    3. By Form
      1. Introduction
        1. Form By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powders
        1. By Value
      5. Solutions
        1. By Value
      6. Others
        1. By Value
    4. By Therapeutic Indication
      1. Introduction
        1. Therapeutic Indication By Value
      2. Cardiovascular Diseases
        1. By Value
      3. Respiratory Diseases
        1. By Value
      4. Gastrointestinal Disorders
        1. By Value
      5. Others
        1. By Value
    5. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Providers
        1. By Value
    6. UAE
      1. By Source
        1. Introduction
          1. Source By Value
        2. Plant-Based
          1. By Value
        3. Algae-Based
          1. By Value
        4. Fungi-Based
          1. By Value
      2. By Form
        1. Introduction
          1. Form By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powders
          1. By Value
        5. Solutions
          1. By Value
        6. Others
          1. By Value
      3. By Therapeutic Indication
        1. Introduction
          1. Therapeutic Indication By Value
        2. Cardiovascular Diseases
          1. By Value
        3. Respiratory Diseases
          1. By Value
        4. Gastrointestinal Disorders
          1. By Value
        5. Others
          1. By Value
      4. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Providers
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Plant-Based
        1. By Value
      3. Algae-Based
        1. By Value
      4. Fungi-Based
        1. By Value
    3. By Form
      1. Introduction
        1. Form By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powders
        1. By Value
      5. Solutions
        1. By Value
      6. Others
        1. By Value
    4. By Therapeutic Indication
      1. Introduction
        1. Therapeutic Indication By Value
      2. Cardiovascular Diseases
        1. By Value
      3. Respiratory Diseases
        1. By Value
      4. Gastrointestinal Disorders
        1. By Value
      5. Others
        1. By Value
    5. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Providers
        1. By Value
    6. Brazil
      1. By Source
        1. Introduction
          1. Source By Value
        2. Plant-Based
          1. By Value
        3. Algae-Based
          1. By Value
        4. Fungi-Based
          1. By Value
      2. By Form
        1. Introduction
          1. Form By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powders
          1. By Value
        5. Solutions
          1. By Value
        6. Others
          1. By Value
      3. By Therapeutic Indication
        1. Introduction
          1. Therapeutic Indication By Value
        2. Cardiovascular Diseases
          1. By Value
        3. Respiratory Diseases
          1. By Value
        4. Gastrointestinal Disorders
          1. By Value
        5. Others
          1. By Value
      4. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Providers
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Botanical Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Devonian Health Group Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Dr. Willmar Schwabe GmbH And Co. KG
    3. Tsumura & Co.
    4. Evonik
    5. Zein Pharma
    6. 21ST Century HealthCare, Inc.
    7. Ransom Naturals Ltd
    8. Abbott Laboratories
    9. Wilson Drugs & Pharmaceuticals Private Limited
    10. Zandu Pharmaceuticals
    11. KPC Pharmaceuticals
    12. Himalaya Wellness Company
    13. Jaguar Health, Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The Ophthalmic Drugs Market size was valued at USD 32.9 billion in 2021. It is projected to reach USD 62.55 billion by 2030, growing at a CAGR of 7.4% during the forecast period (2022-2030).  The ophthalmic drugs market are Anti-infectives in a
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.